Form Type: 4

SEC EDGAR Link
Accession Number:0001140361-21-020429
Date:2021-06-08
Issuer: ATARA BIOTHERAPEUTICS, INC. (ATRA)
Original Submission Date:

Reporting Person:

BAYNES ROY D.
611 GATEWAY BOULEVARD
SUITE 900 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-08 A 11,000 a $0.00 23,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 13.8 2021-06-08 deemed execution date A 17,500 (a) 2031-06-07 common stock 17,500 $13.80 17,500 direct
Footnotes
IDfootnote
f1 these restricted stock units shall vest on the earlier of june 8, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service.
f2 the option shall vest on the earlier of june 8, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service.
WhaleWisdom Logo

Elevate your investments